U.S. health insurer Anthem Inc. said it will exit Obamacare markets in Virginia and reduce its plan offerings in Washington and Scott counties and the city of Bristol in 2018.
The U.S. Food and Drug Administration is advising consumers and health-care professionals not to use any liquid drug or dietary supplement products manufactured by PharmaTech LLC of Davie, Florida, and labeled by Rugby Laboratories, Major Pharmaceuticals and Leader Brands, due to potential contamination with the bacteria Burkholderia cepacia (B. cepacia) and the risk for severe patient infection.
Carlsbad, Calif.-based Ionis Pharmaceuticals announced that GlaxoSmithKline declined its options on both inotersen and IONIS-FB-Lrx, which gives Ionis back control of those rights.
Amid an ongoing organizational restructuring, Perrigo is selling off two of its business units as the company looks to streamline costs and pare down some of its debt.
Feb. 12, 2018, is the day the U.S. FDA is expected to review Gilead Sciences’ HIV treatment that some analysts suggest could become a blockbuster.
After losing $111 million in the first six months of 2017, NantHealth – one of billionaire Patrick Soon-Shiong’s biotech companies – plans to reorganize and lay off 300 people. Approximately half of those people laid off will transfer to Allscripts.
Oral glucosamine – a natural supplement often marketed for joint pain – has no more effect than a dummy pill, according to a new review of available research.
U.S. President Donald Trump declared the opioid epidemic a national emergency and said his administration was drafting papers to make it official.
The number of U.S. adults and children with epilepsy is increasing, with at least 3.4 million people living with the disorder, according to data released in CDC’s Morbidity and Mortality Weekly Report. This is the first time epilepsy estimates have been available for every state.
Artificial intelligence robots are turbo-charging the race to find new drugs for the crippling nerve disorder ALS, or motor neurone disease.